Cargando…
Immunolab: Combining targeted real-world data with advanced analytics to generate evidence at scale in immunology
Real-world evidence (RWE) has traditionally been used by regulatory or payer authorities to inform disease burden, background risk, or conduct post-launch pharmacovigilance, but in recent years RWE has been increasingly used to inform regulatory decision-making. However, RWE data sources remain frag...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668850/ https://www.ncbi.nlm.nih.gov/pubmed/36407087 http://dx.doi.org/10.3389/falgy.2022.951795 |